Zonegran Related Published Studies
Well-designed clinical trials related to Zonegran (Zonisamide)
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. [2007.08]
Zonisamide and renal calculi in patients with epilepsy: how big an issue? [2007.08]
A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. [2007.02]
A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. [2007.01.15]
Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. [2007.01.02]
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. [2006.12]
Zonisamide as adjunctive therapy for refractory partial seizures. [2006.02]
Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. [2005.05]
Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. [2005.03]
Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. [2005.01]
Zonisamide clinical trials: European experience. [2004.12]
Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. [2004.06]
Zonisamide for weight loss in obese adults: a randomized controlled trial. [2003.04.09]
Zonisamide add-on for drug-resistant partial epilepsy. [2002]
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. [2001.11.27]
Zonisamide for drug-resistant partial epilepsy. [2000]
Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. [1993.05]
Well-designed clinical trials possibly related to Zonegran (Zonisamide)
Secondary osteoporosis in long-term bedridden patients with cerebral palsy. [2008.06]
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]
Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs. [2007.05.23]
Postoperative seizures: epidemiology, pathology, and prophylaxis. [2003.12]
Developmental and therapeutic pharmacology of antiepileptic drugs. [2000]
Expanding first-line therapy options for children with partial seizures. [2000]
The new antiepileptic drugs: a systematic review of their efficacy and tolerability. [1997.08]
An overview of the efficacy and tolerability of new antiepileptic drugs. [1997]
Other research related to Zonegran (Zonisamide)
Effects of zonisamide on isolated head tremor. [2008.11]
Population Estimation Regarding the Effects of Cytochrome P450 2C19 and 3A5 Polymorphisms on Zonisamide Clearance. [2008.08]
Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. [2008.08]
Zonisamide concentrations during pregnancy. [2008.07]
Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: a successful use of zonisamide for controlling the seizures. [2008.07]
Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. [2008.06.10]
Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy. [2008.06]
Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy. [2008.06]
Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study. [2008.05]
Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience. [2008.04]
Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. [2008.04]
Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. [2008.03.13]
Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. [2008.03]
[Zonisamide in refractory essential tremor] [2008.02.01]
Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6. [2008.02]
Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients. [2008.01]
Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation. [2008.01]
Is adjunctive open-label zonisamide effective for bipolar disorder? [2008.01]
Long-term use of zonisamide in refractory childhood-onset epilepsy. [2008.01]
Effects of zonisamide on experimental tremors in rats. [2008]
[Anticonvulsant treatment with zonisamide added to topiramate. A preliminary treatment analysis in 19 patients] [2007.12]
Zonisamide for essential tremor. [2007.11]
[Zonisamide and neuropathic pain.] [2007.10.01]
Zonisamide for the treatment of Parkinson's disease. [2007.09]
The supraspinally mediated analgesic effects of zonisamide in mice after peripheral nerve injury are independent of the descending monoaminergic system. [2007.08]
Serotonin but not zonisamide inhibits theophylline-induced epileptiform activity in guinea pig hippocampal CA3 neurons. [2007.08]
Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study. [2007.07.10]
Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. [2007.07]
Clinical pharmacology and mechanism of action of zonisamide. [2007.07]
Adjunctive zonisamide for treatment refractory anxiety. [2007.06]
Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series. [2007.04]
Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. [2007.03]
Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model. [2007.03]
Pharmacokinetics and drug interactions with zonisamide. [2007.03]
Erratum to "Safety of zonisamide therapy: prospective follow-up survey.". [2007.01]
[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant] [2007.01]
Zonisamide for bipolar depression. [2007.01]
Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series. [2007.01]
Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide. [2006.12]
A long-term follow-up of zonisamide monotherapy. [2006.11]
[New medications; zonisamide] [2006.10.21]
Zonisamide for migraine prophylaxis in refractory patients. [2006.10]
Zonisamide eradicated paroxysmal headache with EEG abnormalities triggered by hypertensive encephalopathy due to purpura nephritic syndrome. [2006.10]
Zonisamide for the treatment of epilepsy. [2006.09]
An open prospective study of zonisamide in acute bipolar depression. [2006.08]
Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. [2006.06.16]
Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. [2006.05]
Zonisamide prophylaxis in refractory pediatric headache. [2006.05]
Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide. [2006.05]
Introduction to zonisamide. [2006.02]
Practical prescribing and long-term efficacy and safety of zonisamide. [2006.02]
Zonisamide in the management of epilepsy--Japanese experience. [2006.02]
Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors. [2005.12]
Zonisamide as adjunctive therapy for refractory partial seizures. [2005.11.26]
Zonisamide add-on for drug-resistant partial epilepsy. [2005.10.19]
Zonisamide: review of its use in epilepsy therapy. [2005.09]
Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse. [2005.08]
Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy. [2005.07]
Use of zonisamide in pediatric patients. [2005.07]
Zonisamide for West syndrome: a comparison of clinical responses among different titration rate. [2005.06]
Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. [2005.05]
Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy. [2005.04]
Zonisamide: physician and patient experiences. [2005.03]
Zonisamide for absence seizures. [2005.03]
Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center. [2005.03]
A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. [2005.02]
Zonisamide monotherapy for epilepsy in children and young adults. [2005.02]
Zonisamide: a review of its use in the management of partial seizures in epilepsy. [2005]
Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. [2004.12]
Effects of the antiepileptics phenytoin and zonisamide on dentin formation and bone mineral density of the mandible in growing rats. [2004.12]
Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. [2004.12]
Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy. [2004.12]
Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures. [2004.12]
Safety of zonisamide therapy: prospective follow-up survey. [2004.12]
Efficacy of zonisamide: our experience. [2004.12]
Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey. [2004.12]
|
